Skip to content

Non-Invasive Measurements of Changes in Pulmonary Artery Pressure in Intensive Care Unit Patients Using Electrical Impedance Tomography - A Feasibility Study

Non-Invasive Measurements of Changes in Pulmonary Artery Pressure in Intensive Care Unit Patients Using Electrical Impedance Tomography - A Feasibility Study (PAP-EIT Study)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06544148
Acronym
PAP-EIT
Enrollment
28
Registered
2024-08-09
Start date
2024-08-05
Completion date
2027-08-05
Last updated
2024-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Artery Hypertension

Brief summary

To assess whether changes in electrical impedance - measured using an electrical impedance tomography (EIT) chest belt - can be used to derive changes in pulmonary artery pressure (PAP) in critically ill patients when compared to invasive gold-standard PAP measured using pulmonary artery catheter (PAC).

Interventions

DEVICEElectrical impedance tomography

In addition to routine critical care with a pulmonary artery catheter already in place (PAC), an electrical impedance tomography (EIT) belt will be placed in patients enrolled in this study. Data will be analyzed offline and clinical trajectory and/or decisions will not be impacted by this additional monitoring. EIT is a non-invasive, safe, and radiation-free medical imaging modality.

Sponsors

CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et Developpement
CollaboratorINDUSTRY
Insel Gruppe AG, University Hospital Bern
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18-year-old. * Intubated patients in the ICU with clinical decision to monitor PAP and cardiac output using a PAC.

Exclusion criteria

* Patients with implanted or external thoracic electronic devices (e.g., pacemaker) or thoracic metal implants. * Known pregnancy or lactating patients. * Open lung injuries or pneumothorax. * Open wounds, drainages, burns or rashes of the upper thorax. * Estimated thoracic perimeter smaller than 66 cm or larger than 134 cm. * Known allergies to wound dressings or adhesives (e.g., gel electrodes)

Design outcomes

Primary

MeasureTime frameDescription
Mean difference between EIT-derived and PAC-measured changes in pulmonary artery pressureUp to 48 hoursThe primary outcome is the difference - expressed as mean and standard deviation (SD) - between changes in EIT-derived pulmonary artery pressure (ΔPAP\_EIT), derived from changes in the pulmonary pulse arrival time, and changes in pulmonary artery catheter-based pulmonary artery pressure (ΔPAP\_PAC). This will be measured over recording periods of up to 48 hours.

Secondary

MeasureTime frameDescription
Data acceptance rateUp to 48 hoursData acceptance rate, i.e., the percentage of total recording duration during which lung EIT signals show pulmonary pressure morphology and thus allow to estimate EIT-derived PAP values.
Concordance rate (%) of directional changes in pulmonary artery pressure between EIT and PAC measurements (Trending ability)Up to 48 hoursThe trending ability will be assessed using four quadrant plot analysis to calculate the concordance rate between EIT-derived and PAC-measured pulmonary artery pressure changes. The concordance rate is defined as the percentage of data points in which both methods agree on the direction of change (increase or decrease) in pulmonary artery pressure.
Accuracy and trending ability of EIT-derived cardiac output compared to PAC measurementsUp to 48 hoursThe difference between EIT-derived cardiac output (CO\_EIT) and pulmonary artery catheter-based cardiac output (CO\_PAC) will be calculated. This will be expressed as mean difference ± standard deviation in L/min. The ability of EIT to track changes in cardiac output over time will be evaluated by comparing directional changes in CO\_EIT with corresponding changes in CO\_PAC. This will be reported as the percentage of concordant directional changes between the two methods.
Agreement between EIT-derived and ventilator-measured respiratory parametersUp to 48 hoursThis outcome assesses the ability of EIT to measure key respiratory parameters compared to the mechanical ventilator measurements. The difference between EIT-derived tidal volume and ventilator-measured tidal volume as well as the difference between EIT-derived respiratory rate and ventilator-measured respiratory rate will be calculated and expressed as mean difference ± standard deviation. Other ventilation-related parameters: Additional parameters such as end-expiratory lung volume changes or regional ventilation distribution may also be assessed, depending on the capabilities of the EIT system and the available ventilator data.

Countries

Switzerland

Contacts

Primary ContactKaspar F Bachmann, MD
kaspar.bachmann@faculty.unibe.ch+41 31 632 21 11

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026